The first-floor walls at 4240 Duncan Ave. — home to Washington University in St. Louis’ Office of Technology Management (OTM) — are running out of room. And that’s a good thing. The logos of Washington University startup companies launched to shepherd promising university-owned diagnostics, therapeutics or other technologies to the marketplace are prominently displayed on the walls. […]
Tag: Matthew MacEwan
Inventive pathways
Moving innovations out of the so-called ivory tower and into the public domain holds enormous power to treat disease and improve quality of life. But while academic researchers and physicians may imagine promising clinical solutions, some are unprepared to navigate commercialization: pitching themselves, attracting investors, wrangling with intellectual property law, designing rigorous proof-of-concept studies, locating […]